Inst Diagnosti Valuation
| INDISA Stock | CLP 1,591 4.40 0.28% |
At this time, the firm appears to be overvalued. Inst Diagnosti retains a regular Real Value of 1145.23 per share. The prevalent price of the firm is 1590.6. Our model calculates the value of Inst Diagnosti from evaluating the firm fundamentals such as Return On Asset of 0.0489, return on equity of 0.19, and Current Valuation of 329.99 B as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Inst Diagnosti's price fluctuation is very steady at this time. Calculation of the real value of Inst Diagnosti is based on 3 months time horizon. Increasing Inst Diagnosti's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Inst Diagnosti is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Inst Stock. However, Inst Diagnosti's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1590.6 | Real 1145.23 | Hype 1590.6 | Naive 1634.37 |
The real value of Inst Stock, also known as its intrinsic value, is the underlying worth of Inst Diagnosti Company, which is reflected in its stock price. It is based on Inst Diagnosti's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Inst Diagnosti's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Inst Diagnosti helps investors to forecast how Inst stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Inst Diagnosti more accurately as focusing exclusively on Inst Diagnosti's fundamentals will not take into account other important factors: Inst Diagnosti Total Value Analysis
Inst Diagnosti is currently forecasted to have takeover price of 329.99 B with market capitalization of 216 B, debt of 33.85 B, and cash on hands of 18.3 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Inst Diagnosti fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
329.99 B | 216 B | 33.85 B | 18.3 B |
Inst Diagnosti Investor Information
About 33.0% of the company shares are held by company insiders. The book value of Inst Diagnosti was currently reported as 722.14. The company recorded earning per share (EPS) of 135.0. Inst Diagnosti last dividend was issued on the 11th of May 2022. The entity had 1:1 split on the 12th of March 2018. Inst Diagnosti is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Inst Diagnosti Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Inst Diagnosti has an asset utilization ratio of 81.66 percent. This suggests that the Company is making 0.82 for each dollar of assets. An increasing asset utilization means that Inst Diagnosti is more efficient with each dollar of assets it utilizes for everyday operations.Inst Diagnosti Ownership Allocation
Inst Diagnosti has a total of 140.93 Million outstanding shares. Inst Diagnosti secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Inst Diagnosti Profitability Analysis
The company reported the revenue of 188.54 B. Net Income was 20.65 B with profit before overhead, payroll, taxes, and interest of 50.69 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Inst Diagnosti's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Inst Diagnosti and how it compares across the competition.
About Inst Diagnosti Valuation
The stock valuation mechanism determines Inst Diagnosti's current worth on a weekly basis. Our valuation model uses a comparative analysis of Inst Diagnosti. We calculate exposure to Inst Diagnosti's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Inst Diagnosti's related companies.Instituto de Diagnstico S.A. provides healthcare services in various medical specialties and sub-specialties in Chile. The company was founded in 1961 and is based in Providencia, Chile. INST DIAGNOSTICO is traded on Commodity Exchange in Exotistan.
8 Steps to conduct Inst Diagnosti's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Inst Diagnosti's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Inst Diagnosti's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Inst Diagnosti's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Inst Diagnosti's revenue streams: Identify Inst Diagnosti's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Inst Diagnosti's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Inst Diagnosti's growth potential: Evaluate Inst Diagnosti's management, business model, and growth potential.
- Determine Inst Diagnosti's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Inst Diagnosti's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Inst Stock analysis
When running Inst Diagnosti's price analysis, check to measure Inst Diagnosti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inst Diagnosti is operating at the current time. Most of Inst Diagnosti's value examination focuses on studying past and present price action to predict the probability of Inst Diagnosti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inst Diagnosti's price. Additionally, you may evaluate how the addition of Inst Diagnosti to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |